Stay updated with breaking news from Brook Baker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company behind COVAX, a COVID-19 vaccine touted as a key tool for the developing world, has sent tens of millions of doses to wealthy nations but provided none yet to the UN-backed effort to supply poorer countries, a sign that inequity persists in the global response to the pandemic.
The company behind a COVID-19 vaccine will miss a target for giving doses to the U.N.-backed effort to deliver shots to poorer countries.
Some health officials say the discrepancy between rich and poor countries is discriminatory and has denied poor countries a chance to stem the spread of the coronavirus in the absence of vaccines.
HARARE, Zimbabwe — After learning that a friend tested positive for COVID-19, Thembi Ndlovu went to a health clinic in Zimbabwe's capital in search of a free coronavirus test. But there were none left that day, leaving the 34-year-old hairdresser unsure if she needed to take precautions to protect clients.
HARARE, Zimbabwe (AP) — After learning that a friend tested positive for COVID-19, Thembi Ndlovu went to a health clinic in Zimbabwe's capital in search of a free coronavirus test. But there were none left that day, leaving the 34-year-old hairdresser unsure if she needed to take precautions to protect clients.